Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone posterior segment drug delivery system for non-infectious intermediate or posterior uveitis
2006-000736-26Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in uveitis (3 arms), sponsored by Allergan. Primary endpoint: Vitreous haze. Started Feb 2006; status: completed.
02
Drugs
dexamethasone
03
Conditions
uveitis
Beyond the preview
Go deeper on 2006-000736-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000736-26.